Great Debates & Updates in Thoracic Malignancies

7. 5. 2011 - 7. 5. 2011, Sheraton Fishermans Wharf Hotel, San Francisco, California, USA

Témata:

  • Is it time for a new taxane?
  • Maintenance therapy
  • Screen everyone for EGFR mutations?
  • Appropriate setting for EGFR TKIs
  • EGFR TKI’s – only for mutation patients?
  • Surgery for stage IIIa patients with lung cancer
  • Is two cycles of chemoradiation enough?

Registrace

  • Zlevněná registrace do 14. března 2011
  • Běžná registrace do 28. dubna 2011
  • Online registrace
Saturday, May 7, 2011
Moderator: Ramaswamy Govindan, MD

8:00 am
Welcome and introduction
Ramaswamy Govindan, MD

8:05 am
Is it time for a new taxane?

Yes
Suresh S. Ramalingam, MD

No
Primo Lara, MD

8:50 am
Maintenance therapy

Yes
Alan B. Sandler, MD

No
Speaker invited

9:35 am
Screen everyone with metastatic NSCLC for EGFR mutations?

Yes
Anne S. Tsao, MD

No
Heather A. Wakelee, MD

10:20 am
Break

10:40 am
Appropriate setting for EGFR TKIs Frontline/maintenance
Alan B. Sandler, MD

Second line and beyond
Suresh S. Ramalingam, MD

11:25 am
EGFR TKIs Only for mutation patients
Primo Lara, MD

No, for everyone
Karen L. Kelly, MD

12:10 pm
Lunch

1:00 pm
Surgery for stage IIIa patients with lung cancer

Sometimes
Anne S. Tsao, MD

Never
Speaker invited

1:45 pm
Two cycles of chemoradiation 2 cycles is enough
Heather A. Wakelee, MD

2 cycles is not enough
Karen L. Kelly, MD

2:30
Closing notes and adjourn

Kontakt: meetings@imedex.com

Web: http://www.imedex....ements/a254-01.asp

  • Sdílejte na:
    • Facebook
    • Twitter
    • Del.icio.us
    • Digg
    • Google
    • Reddit
    • StumbleUpon
    • Live